Cerus to Present at the Cowen and Company 36th Annual Health Care Conference on March 9, 2016
Get Alerts CERS Hot Sheet
Join SI Premium – FREE
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ: CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Cowen and Company 36th Annual Health Care Conference at 10:40 am ET on Wednesday, March 9, 2016.
A live webcast of the presentation will be available on the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.
ABOUT CERUS
Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for information about Cerus.
INTERCEPT and INTERCEPT Blood System are trademarks of Cerus Corporation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160302005002/en/
Cerus Corporation
Stacey Leanos, 925-288-6137
Associate
Director, Investor & Public Relations
[email protected]
Source: Cerus Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PDD Holdings Files Annual Report on Form 20-F for Fiscal Year 2023
- Founders Metals Engages Blue Coast Research for Preliminary Metallurgical Test Work
- Blue Star Gold Announces 2024 Exploration Program Mobilization
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!